""	"Name"	"Genes (tot)"	"Stat (dist.dir.up)"	"p (dist.dir.up)"	"p adj (dist.dir.up)"	"Stat (dist.dir.dn)"	"p (dist.dir.dn)"	"p adj (dist.dir.dn)"	"Stat (non-dir.)"	"p (non-dir.)"	"p adj (non-dir.)"	"Genes (up)"	"Stat (mix.dir.up)"	"p (mix.dir.up)"	"p adj (mix.dir.up)"	"Genes (down)"	"Stat (mix.dir.dn)"	"p (mix.dir.dn)"	"p adj (mix.dir.dn)"
"1"	"ABC transporters"	11	-0.37855	0.78071	0.9963	0.37855	0.21929	0.93786	-14.11	0.87703	0.99992	5	-15.054	0.98953	0.99785	6	-5.3625	0.31653	0.87169
"2"	"AGE-RAGE signaling pathway in diabetic complications"	39	-0.12066	0.58282	0.93559	0.12066	0.41718	1	-17.589	0.36088	0.72932	18	-12.505	0.39954	0.73853	21	-12.393	0.4121	0.93776
"3"	"AMPK signaling pathway"	56	0.49118	0.1609	0.61344	-0.49118	0.8391	1	-20.82	0.30168	0.63456	27	-10.19	0.038622	0.3246	29	-19.099	0.84091	0.99976
"4"	"Acute myeloid leukemia"	28	0.17278	0.35173	0.85764	-0.17278	0.64827	1	-19.613	0.83174	0.99992	14	-12.786	0.63491	0.86254	14	-14.951	0.87624	0.99976
"5"	"Adherens junction"	32	0.51115	0.15492	0.59809	-0.51115	0.84508	1	-15.452	0.30498	0.63711	19	-13.575	0.50405	0.79128	13	-7.8327	0.22935	0.78406
"6"	"Adipocytokine signaling pathway"	31	0.88906	0.042422	0.3009	-0.88906	0.95758	1	-19.036	0.74683	0.99992	16	-8.9678	0.15721	0.51814	15	-18.105	0.97649	0.99976
"7"	"Adrenergic signaling in cardiomyocytes"	57	0.60095	0.1045	0.50174	-0.60095	0.8955	1	-16.054	0.023439	0.24442	30	-11.333	0.056682	0.34702	27	-11.379	0.13901	0.69269
"8"	"African trypanosomiasis"	14	1.8506	0.00014432	0.0084097	-1.8506	0.99986	1	-5.3852	0.047209	0.29493	13	-3.3116	0.013235	0.20688	1	-8.2095	0.93497	0.99976
"9"	"Alanine, aspartate and glutamate metabolism"	16	-0.68089	0.89974	1	0.68089	0.10026	0.7649	-6.2212	0.044842	0.29493	6	-6.104	0.32268	0.69953	10	-3.1412	0.039701	0.47053
"10"	"Alcoholism"	29	0.91296	0.026621	0.23881	-0.91296	0.97338	1	-12.664	0.13634	0.45201	17	-10.472	0.24587	0.59854	12	-7.223	0.20313	0.78406
"11"	"Aldosterone synthesis and secretion"	24	-0.34854	0.75911	0.99213	0.34854	0.24089	0.93786	-11.156	0.16273	0.47723	13	-10.213	0.39018	0.73853	11	-5.3768	0.10784	0.65465
"12"	"Aldosterone-regulated sodium reabsorption"	16	-0.62393	0.87889	1	0.62393	0.12111	0.79292	-11.263	0.39272	0.75809	6	-4.6499	0.19671	0.55641	10	-10.645	0.65598	0.99976
"13"	"Allograft rejection"	4	0.0098371	0.47531	0.88954	-0.0098371	0.52469	1	-8.8063	0.77687	0.99992	2	-6.2114	0.69287	0.87557	2	-6.2426	0.74938	0.99976
"14"	"Alzheimer disease"	113	-0.55502	0.85348	1	0.55502	0.14652	0.83335	-21.549	0.0011794	0.05837	42	-14.831	0.051187	0.34702	71	-15.778	0.0062255	0.28965
"15"	"Amino sugar and nucleotide sugar metabolism"	27	-1.1896	0.98975	1	1.1896	0.010246	0.24038	-7.8103	0.01303	0.18392	14	-10.684	0.39931	0.73853	13	-0.16865	0.0015432	0.09288
"16"	"Aminoacyl-tRNA biosynthesis"	21	0.42427	0.19326	0.65758	-0.42427	0.80674	1	-10.946	0.21001	0.54283	14	-9.4424	0.2711	0.63901	7	-5.6052	0.27925	0.8504
"17"	"Amoebiasis"	42	0.23521	0.3176	0.82329	-0.23521	0.6824	1	-16.992	0.22866	0.56242	25	-15.376	0.48585	0.78852	17	-8.0611	0.13277	0.68479
"18"	"Amphetamine addiction"	20	-0.36615	0.76678	0.99213	0.36615	0.23322	0.93786	-7.281	0.040354	0.28913	9	-6.38	0.19663	0.55641	11	-4.0467	0.051305	0.47473
"19"	"Amyotrophic lateral sclerosis (ALS)"	21	-0.30235	0.71951	0.99213	0.30235	0.28049	0.97306	-7.9132	0.048611	0.29653	9	-4.6614	0.088786	0.41054	12	-6.4312	0.14571	0.70228
"20"	"Antigen processing and presentation"	24	0.17436	0.37418	0.85764	-0.17436	0.62582	1	-11.346	0.17653	0.49854	15	-9.1443	0.20463	0.56273	9	-6.723	0.28925	0.8504
"21"	"Apelin signaling pathway"	54	1.6571	0.00055349	0.021628	-1.6571	0.99945	1	-20.169	0.27006	0.61304	35	-15.156	0.17401	0.53531	19	-13.432	0.60607	0.99976
"22"	"Apoptosis"	49	0.40707	0.19638	0.65821	-0.40707	0.80362	1	-24.954	0.87528	0.99992	22	-14.692	0.47255	0.77929	27	-20.355	0.93689	0.99976
"23"	"Arachidonic acid metabolism"	15	-0.16877	0.62311	0.96748	0.16877	0.37689	1	-11.139	0.42961	0.79413	5	-2.4014	0.092766	0.41309	10	-11.944	0.78079	0.99976
"24"	"Arginine and proline metabolism"	27	0.41489	0.21231	0.67452	-0.41489	0.78769	1	-6.5578	0.0049582	0.13947	14	-4.3372	0.019374	0.23975	13	-4.9499	0.057594	0.49802
"25"	"Arginine biosynthesis"	11	-0.24036	0.69124	0.99213	0.24036	0.30876	0.97306	-5.3031	0.089	0.40403	5	-6.7931	0.47492	0.77929	6	-0.97916	0.043212	0.47053
"26"	"Arrhythmogenic right ventricular cardiomyopathy (ARVC)"	36	0.25712	0.31419	0.82329	-0.25712	0.68581	1	-16.556	0.31933	0.65807	19	-10.843	0.22572	0.57298	17	-12.629	0.57367	0.99976
"27"	"Ascorbate and aldarate metabolism"	6	2.0152	4.5623e-05	0.0034787	-2.0152	0.99995	1	-3.1166	0.097861	0.40403	5	0.2574	0.018429	0.23797	1	-8.2095	0.93497	0.99976
"28"	"Asthma"	2	-0.24216	0.68089	0.99213	0.24216	0.31911	0.9733	-6.2426	0.71928	0.99992	0				2	-6.2426	0.74938	0.99976
"29"	"Autoimmune thyroid disease"	4	0.0098371	0.47531	0.88954	-0.0098371	0.52469	1	-8.8063	0.77687	0.99992	2	-6.2114	0.69287	0.87557	2	-6.2426	0.74938	0.99976
"30"	"Autophagy"	56	0.63635	0.098152	0.49894	-0.63635	0.90185	1	-26.451	0.86817	0.99992	27	-16.426	0.50613	0.79128	29	-20.908	0.93342	0.99976
"31"	"Axon guidance"	55	-0.19349	0.65783	0.99154	0.19349	0.34217	1	-23.261	0.60659	0.96986	28	-18.336	0.68505	0.87557	27	-14.527	0.43329	0.93776
"32"	"B cell receptor signaling pathway"	27	-0.43295	0.80177	0.99933	0.43295	0.19823	0.93786	-19.211	0.83938	0.99992	13	-14.964	0.85475	0.95437	14	-12.26	0.65037	0.99976
"33"	"Bacterial invasion of epithelial cells"	42	0.65118	0.096825	0.49894	-0.65118	0.90318	1	-18.751	0.40436	0.76602	25	-14.674	0.40495	0.73853	17	-11.678	0.4662	0.93776
"34"	"Basal cell carcinoma"	4	0.01492	0.47112	0.88954	-0.01492	0.52888	1	-13.305	0.97933	0.99992	3	-10.623	0.93232	0.98191	1	-8.2095	0.93497	0.99976
"35"	"Basal transcription factors"	4	2.1076	5.2704e-06	0.00053582	-2.1076	0.99999	1	-6.4028	0.53134	0.90535	4	-6.4028	0.51972	0.79128	0			
"36"	"Base excision repair"	8	0.78508	0.052843	0.35037	-0.78508	0.94716	1	-14.998	0.96385	0.99992	5	-10.572	0.84663	0.95437	3	-10.844	0.95124	0.99976
"37"	"Bile secretion"	15	-0.36531	0.75833	0.99213	0.36531	0.24167	0.93786	-9.7505	0.28662	0.62747	9	-9.5267	0.52066	0.79128	6	-3.749	0.17546	0.76131
"38"	"Biosynthesis of unsaturated fatty acids"	11	-0.33956	0.75708	0.99213	0.33956	0.24292	0.93786	-9.378	0.42589	0.79204	3	-1.5974	0.13985	0.48592	8	-10.018	0.69467	0.99976
"39"	"Bladder cancer"	12	-0.080411	0.55001	0.92173	0.080411	0.44999	1	-11.782	0.63827	0.98389	7	-8.5315	0.52752	0.79128	5	-8.1576	0.71305	0.99976
"40"	"Breast cancer"	22	0.014058	0.48614	0.88954	-0.014058	0.51386	1	-20.196	0.95772	0.99992	12	-14.333	0.84517	0.95437	10	-14.253	0.92482	0.99976
"41"	"Butanoate metabolism"	16	1.6073	0.00077638	0.023163	-1.6073	0.99922	1	-8.7174	0.16069	0.47584	11	-2.6106	0.014369	0.21073	5	-11.722	0.94957	0.99976
"42"	"C-type lectin receptor signaling pathway"	33	-0.16192	0.63541	0.96973	0.16192	0.36459	1	-18.659	0.63872	0.98389	15	-11.533	0.447	0.76297	18	-14.737	0.74328	0.99976
"43"	"Calcium signaling pathway"	51	-0.44081	0.80602	0.99933	0.44081	0.19398	0.93786	-14.455	0.024041	0.24442	24	-12.113	0.19935	0.55855	27	-8.4465	0.02625	0.3746
"44"	"Carbohydrate digestion and absorption"	12	-0.29556	0.70323	0.99213	0.29556	0.29677	0.97306	-6.7982	0.13603	0.45201	6	-6.641	0.37637	0.73853	6	-2.9731	0.1247	0.67723
"45"	"Cardiac muscle contraction"	41	-0.050471	0.51706	0.89097	0.050471	0.48294	1	-10.899	0.0079968	0.17422	16	-5.3903	0.023406	0.25261	25	-9.645	0.092815	0.64242
"46"	"Cell adhesion molecules (CAMs)"	24	0.052977	0.46691	0.88954	-0.052977	0.53309	1	-24.291	0.99744	0.99992	11	-16.248	0.95986	0.99785	13	-18.059	0.98674	0.99976
"47"	"Cell cycle"	32	0.16478	0.37174	0.85764	-0.16478	0.62826	1	-26.533	0.99604	0.99992	20	-23.308	0.99449	0.99785	12	-13.238	0.80922	0.99976
"48"	"Cellular senescence"	49	0.29289	0.26383	0.76187	-0.29289	0.73617	1	-17.88	0.16905	0.49106	28	-14.916	0.30688	0.68529	21	-10.089	0.18668	0.78226
"49"	"Central carbon metabolism in cancer"	33	-0.36561	0.76538	0.99213	0.36561	0.23462	0.93786	-13.724	0.15324	0.4696	16	-11.828	0.41255	0.73853	17	-7.6466	0.10911	0.65465
"50"	"Chagas disease (American trypanosomiasis)"	33	0.60297	0.142	0.58528	-0.60297	0.858	1	-20.183	0.78238	0.99992	18	-12.518	0.40095	0.73853	15	-16.223	0.9254	0.99976
"51"	"Chemical carcinogenesis"	21	0.28608	0.27737	0.7833	-0.28608	0.72263	1	-8.4761	0.066768	0.34516	10	-2.0592	0.012209	0.20688	11	-9.748	0.52299	0.98598
"52"	"Chemokine signaling pathway"	50	0.86958	0.04168	0.3009	-0.86958	0.95832	1	-25.447	0.88164	0.99992	28	-17.871	0.63601	0.86254	22	-18.202	0.90964	0.99976
"53"	"Cholesterol metabolism"	21	0.94314	0.028752	0.24582	-0.94314	0.97125	1	-7.126	0.030078	0.26802	15	-5.2999	0.026246	0.25984	6	-4.9516	0.27646	0.8504
"54"	"Choline metabolism in cancer"	35	-0.30604	0.73522	0.99213	0.30604	0.26478	0.943	-20.345	0.74932	0.99992	14	-11.811	0.52657	0.79128	21	-16.622	0.84244	0.99976
"55"	"Cholinergic synapse"	30	0.012179	0.47714	0.88954	-0.012179	0.52286	1	-15.753	0.40049	0.76344	16	-11.83	0.41278	0.73853	14	-10.414	0.44356	0.93776
"56"	"Chronic myeloid leukemia"	30	0.45666	0.17615	0.63542	-0.45666	0.82385	1	-21.697	0.93067	0.99992	16	-15.442	0.77967	0.92187	14	-15.254	0.89309	0.99976
"57"	"Circadian entrainment"	29	0.22377	0.28604	0.78595	-0.22377	0.71396	1	-12.377	0.11936	0.42828	14	-7.3476	0.11362	0.44453	15	-10.111	0.37317	0.9067
"58"	"Circadian rhythm"	9	0.059851	0.4611	0.88954	-0.059851	0.5389	1	-7.7474	0.36336	0.72932	3	-1.3311	0.12365	0.45182	6	-8.5474	0.66329	0.99976
"59"	"Citrate cycle (TCA cycle)"	29	-0.15232	0.572	0.93559	0.15232	0.428	1	-8.7095	0.013266	0.18392	11	-7.5646	0.22448	0.57298	18	-5.1414	0.02318	0.3746
"60"	"Cocaine addiction"	10	0.50258	0.16768	0.62384	-0.50258	0.83232	1	-6.0919	0.15906	0.47563	6	-6.6626	0.3786	0.73853	4	-1.4721	0.10473	0.65465
"61"	"Collecting duct acid secretion"	11	-0.73154	0.93025	1	0.73154	0.069748	0.75043	-4.6943	0.064222	0.33772	3	-5.5464	0.51807	0.79128	8	-2.1081	0.047807	0.47473
"62"	"Colorectal cancer"	31	0.32403	0.26367	0.76187	-0.32403	0.73633	1	-20.269	0.84588	0.99992	16	-14.144	0.66092	0.87296	15	-14.53	0.82979	0.99976
"63"	"Complement and coagulation cascades"	38	2.3831	1.9668e-06	0.00048665	-2.3831	1	1	-14.465	0.11728	0.42745	34	-10.998	0.021113	0.24937	4	-12.521	0.97224	0.99976
"64"	"Cortisol synthesis and secretion"	9	0.58258	0.12358	0.54506	-0.58258	0.87642	1	-6.6469	0.25309	0.59505	6	-6.9856	0.41222	0.73853	3	-1.6336	0.15727	0.74577
"65"	"Cushing syndrome"	33	-0.31249	0.7341	0.99213	0.31249	0.2659	0.943	-18.824	0.65574	0.99337	18	-17.646	0.88444	0.98014	15	-8.5893	0.22266	0.78406
"66"	"Cysteine and methionine metabolism"	29	-0.29957	0.68216	0.99213	0.29957	0.31784	0.9733	-5.3605	0.00076735	0.05837	13	-2.836	0.0093121	0.20688	16	-4.6604	0.023304	0.3746
"67"	"Cytokine-cytokine receptor interaction"	3	0.21813	0.36462	0.85764	-0.21813	0.63538	1	-9.7916	0.88166	0.99992	3	-9.7916	0.89546	0.98191	0			
"68"	"Cytosolic DNA-sensing pathway"	11	0.27147	0.3015	0.80665	-0.27147	0.6985	1	-20.345	0.99833	0.99992	4	-8.4924	0.74097	0.88737	7	-19.084	0.99966	0.99976
"69"	"D-Glutamine and D-glutamate metabolism"	3	0.20673	0.37266	0.85764	-0.20673	0.62734	1	-6.3904	0.59074	0.9622	2	-6.1971	0.69147	0.87557	1	-2.3045	0.43657	0.93776
"70"	"DNA replication"	9	-0.51581	0.85752	1	0.51581	0.14248	0.83335	-13.003	0.87619	0.99992	6	-12.709	0.90753	0.98191	3	-4.5497	0.43539	0.93776
"71"	"Dilated cardiomyopathy (DCM)"	45	1.3521	0.0028263	0.057467	-1.3521	0.99717	1	-14.112	0.047382	0.29493	25	-6.6702	0.0049577	0.20688	20	-13.71	0.59946	0.99976
"72"	"Dopaminergic synapse"	46	0.10186	0.42258	0.88954	-0.10186	0.57742	1	-15.927	0.10904	0.41059	24	-11.869	0.18108	0.53531	22	-10.634	0.19956	0.78226
"73"	"Drug metabolism"	38	0.17856	0.36291	0.85764	-0.17856	0.63709	1	-13.994	0.093481	0.40403	22	-9.0165	0.04752	0.34702	16	-10.993	0.44463	0.93776
"74"	"ECM-receptor interaction"	38	0.13887	0.39206	0.85764	-0.13887	0.60794	1	-15.915	0.21591	0.54876	19	-7.3135	0.04099	0.32903	19	-15.194	0.78307	0.99976
"75"	"Endocrine and other factor-regulated calcium reabsorption"	21	0.14025	0.38201	0.85764	-0.14025	0.61799	1	-11.714	0.27738	0.62207	16	-13.529	0.59723	0.83276	5	0.19631	0.024698	0.3746
"76"	"Endocytosis"	125	1.0081	0.026035	0.23881	-1.0081	0.97397	1	-29.481	0.10643	0.41059	80	-24.331	0.14226	0.48592	45	-16.694	0.19268	0.78226
"77"	"Endometrial cancer"	20	0.27239	0.31218	0.82329	-0.27239	0.68782	1	-15.408	0.70057	0.99733	12	-11.501	0.57955	0.81191	8	-10.276	0.71904	0.99976
"78"	"Epithelial cell signaling in Helicobacter pylori infection"	30	-0.63601	0.88791	1	0.63601	0.11209	0.79024	-18.192	0.67689	0.99477	12	-17.107	0.96519	0.99785	18	-9.5183	0.21612	0.78406
"79"	"Epstein-Barr virus infection"	74	-1.8419	0.99988	1	1.8419	0.00011852	0.00723	-31.582	0.9403	0.99992	28	-23.454	0.97492	0.99785	46	-21.759	0.7499	0.99976
"80"	"ErbB signaling pathway"	39	-0.45102	0.80331	0.99933	0.45102	0.19669	0.93786	-21.29	0.75652	0.99992	17	-14.346	0.66078	0.87296	22	-15.736	0.73487	0.99976
"81"	"Estrogen signaling pathway"	34	0.55437	0.13891	0.58038	-0.55437	0.86109	1	-14.206	0.17494	0.49854	20	-11.146	0.22103	0.57298	14	-8.8161	0.2745	0.8504
"82"	"Ether lipid metabolism"	10	-0.6895	0.91057	1	0.6895	0.089426	0.7649	-14.159	0.9077	0.99992	2	-11.61	0.97762	0.99785	8	-10.026	0.69536	0.99976
"83"	"Fanconi anemia pathway"	5	-0.21616	0.63126	0.96973	0.21616	0.36874	1	-9.4902	0.77323	0.99992	3	-7.3548	0.71264	0.88737	2	-5.9976	0.72665	0.99976
"84"	"Fat digestion and absorption"	9	0.86525	0.041792	0.3009	-0.86525	0.95821	1	-5.4046	0.1537	0.4696	6	-3.2215	0.10755	0.44453	3	-4.8052	0.46462	0.93776
"85"	"Fatty acid biosynthesis"	7	0.063869	0.44395	0.88954	-0.063869	0.55605	1	-4.6776	0.17391	0.49854	3	-1.0844	0.10986	0.44453	4	-5.2488	0.43188	0.93776
"86"	"Fatty acid degradation"	32	1.8066	0.00016544	0.0084097	-1.8066	0.99983	1	-11.707	0.057055	0.31493	23	-5.4737	0.0034305	0.20377	9	-13.325	0.90802	0.99976
"87"	"Fatty acid elongation"	15	0.33244	0.25018	0.76187	-0.33244	0.74982	1	-7.1193	0.09773	0.40403	9	-2.4639	0.023815	0.25261	6	-8.239	0.63096	0.99976
"88"	"Fc epsilon RI signaling pathway"	27	-0.46942	0.82089	1	0.46942	0.17911	0.93786	-16.992	0.64271	0.98506	10	-12.257	0.72902	0.88737	17	-12.013	0.50421	0.97824
"89"	"Fc gamma R-mediated phagocytosis"	41	-0.045813	0.51344	0.89097	0.045813	0.48656	1	-16.614	0.20989	0.54283	22	-13.438	0.33632	0.70792	19	-9.9463	0.22764	0.78406
"90"	"Ferroptosis"	21	0.00077858	0.49107	0.89097	-0.00077858	0.50893	1	-5.773	0.011917	0.18392	11	-2.8669	0.017297	0.2335	10	-5.359	0.13199	0.68479
"91"	"Fluid shear stress and atherosclerosis"	58	0.9873	0.022377	0.22016	-0.9873	0.97762	1	-24.658	0.67504	0.99477	33	-15.003	0.20683	0.56357	25	-20.321	0.94845	0.99976
"92"	"Focal adhesion"	101	1.1083	0.013328	0.15812	-1.1083	0.98667	1	-25.774	0.10281	0.41059	51	-13.849	0.0090797	0.20688	50	-22.645	0.73333	0.99976
"93"	"Folate biosynthesis"	11	-0.75161	0.93545	1	0.75161	0.064551	0.72918	-4.0528	0.044296	0.29493	5	-5.0079	0.28248	0.6606	6	-0.91594	0.0416	0.47053
"94"	"FoxO signaling pathway"	42	0.32253	0.25859	0.76187	-0.32253	0.74141	1	-18.519	0.37892	0.73662	20	-10.522	0.17398	0.53531	22	-15.555	0.71749	0.99976
"95"	"Fructose and mannose metabolism"	21	-1.5779	0.9991	1	1.5779	0.00089783	0.03912	-5.8025	0.012177	0.18392	5	-6.4489	0.43575	0.75244	16	-3.0425	0.0068964	0.28965
"96"	"GABAergic synapse"	19	-0.15216	0.61488	0.9667	0.15216	0.38512	1	-10.696	0.24358	0.58243	10	-11.001	0.60159	0.83479	9	-3.9447	0.088754	0.64242
"97"	"Galactose metabolism"	15	-1.4752	0.99806	1	1.4752	0.0019397	0.060408	-3.7539	0.012874	0.18392	5	-4.1163	0.20284	0.56273	10	-1.6869	0.014929	0.3746
"98"	"Gap junction"	28	0.052667	0.44034	0.88954	-0.052667	0.55966	1	-13.992	0.28802	0.62747	15	-10.786	0.36339	0.72924	13	-8.9477	0.33785	0.88939
"99"	"Gastric acid secretion"	23	-0.83584	0.93912	1	0.83584	0.060884	0.72918	-7.2542	0.019288	0.23868	11	-7.3932	0.20994	0.56683	12	-2.9646	0.020779	0.3746
"100"	"Gastric cancer"	29	-0.033055	0.47797	0.88954	0.033055	0.52203	1	-24.111	0.98419	0.99992	17	-20.167	0.9808	0.99785	12	-13.478	0.82718	0.99976
"101"	"Glioma"	25	-0.35268	0.74402	0.99213	0.35268	0.25598	0.94152	-17.747	0.78777	0.99992	13	-14.014	0.78522	0.92187	12	-11.03	0.59826	0.99976
"102"	"Glucagon signaling pathway"	49	-1.0871	0.98049	1	1.0871	0.019505	0.4011	-17.466	0.13978	0.45743	20	-11.124	0.21922	0.57298	29	-13.466	0.28443	0.8504
"103"	"Glutamatergic synapse"	27	-0.15373	0.62011	0.96748	0.15373	0.37989	1	-11.71	0.13034	0.45176	14	-10.118	0.33847	0.70792	13	-6.3764	0.12253	0.67723
"104"	"Glutathione metabolism"	34	0.29881	0.28215	0.78424	-0.29881	0.71785	1	-9.6551	0.012962	0.18392	17	-5.0752	0.013117	0.20688	17	-8.5792	0.167	0.75009
"105"	"Glycerolipid metabolism"	20	0.71077	0.09244	0.49376	-0.71077	0.90756	1	-8.8644	0.096148	0.40403	12	-6.0007	0.083391	0.39947	8	-6.6664	0.33988	0.88939
"106"	"Glycerophospholipid metabolism"	29	-1.0677	0.97716	1	1.0677	0.022837	0.43532	-19.626	0.80984	0.99992	12	-15.709	0.92102	0.98191	17	-12.434	0.55182	0.99976
"107"	"Glycine, serine and threonine metabolism"	17	0.42022	0.17917	0.63542	-0.42022	0.82083	1	-7.0916	0.073385	0.36692	7	-0.14023	0.010427	0.20688	10	-9.129	0.48647	0.95988
"108"	"Glycolysis / Gluconeogenesis"	47	-2.1329	0.99998	1	2.1329	2.109e-05	0.0016081	-4.6725	2.7056e-06	0.00082521	16	-2.6126	0.0029754	0.20377	31	-3.8764	0.00020436	0.03004
"109"	"Glycosaminoglycan degradation"	5	1.1293	0.011804	0.15208	-1.1293	0.9882	1	-7.1392	0.54185	0.91746	5	-7.1392	0.51454	0.79128	0			
"110"	"Glycosphingolipid biosynthesis"	2	0.64485	0.10702	0.50174	-0.64485	0.89298	1	-0.55773	0.1498	0.4696	2	-0.55773	0.14234	0.48592	0			
"111"	"Glycosylphosphatidylinositol (GPI)-anchor biosynthesis"	4	0.10593	0.39708	0.85894	-0.10593	0.60292	1	-8.8718	0.78239	0.99992	2	-6.0962	0.68151	0.87557	2	-6.4505	0.76785	0.99976
"112"	"Glyoxylate and dicarboxylate metabolism"	23	0.031118	0.45803	0.88954	-0.031118	0.54197	1	-5.9784	0.0077483	0.17422	12	-4.0401	0.025768	0.25984	11	-4.4251	0.064234	0.5104
"113"	"GnRH signaling pathway"	33	-0.42933	0.80005	0.99933	0.42933	0.19995	0.93786	-14.221	0.18841	0.52241	12	-8.8719	0.28905	0.67069	21	-11.121	0.27727	0.8504
"114"	"Graft-versus-host disease"	4	0.0098371	0.47531	0.88954	-0.0098371	0.52469	1	-8.8063	0.77687	0.99992	2	-6.2114	0.69287	0.87557	2	-6.2426	0.74938	0.99976
"115"	"HIF-1 signaling pathway"	51	-0.71746	0.92159	1	0.71746	0.078413	0.75043	-16.722	0.090116	0.40403	24	-13.391	0.31137	0.68663	27	-10.357	0.083391	0.62864
"116"	"Hedgehog signaling pathway"	9	-0.23621	0.69233	0.99213	0.23621	0.30767	0.97306	-13.005	0.87632	0.99992	1	-8.2095	0.92991	0.98191	8	-10.892	0.77316	0.99976
"117"	"Hematopoietic cell lineage"	14	0.96565	0.029015	0.24582	-0.96565	0.97098	1	-12.383	0.60914	0.96986	6	-3.3716	0.11525	0.44453	8	-13.461	0.9273	0.99976
"118"	"Hepatitis B"	53	0.10002	0.38994	0.85764	-0.10002	0.61006	1	-26.707	0.91363	0.99992	26	-18.436	0.73946	0.88737	27	-19.326	0.89057	0.99976
"119"	"Hepatitis C"	50	-0.26326	0.69053	0.99213	0.26326	0.30947	0.97306	-26.595	0.93585	0.99992	23	-16.88	0.69574	0.87557	27	-20.612	0.94565	0.99976
"120"	"Hepatocellular carcinoma"	43	0.10358	0.41642	0.88954	-0.10358	0.58358	1	-23.287	0.84677	0.99992	22	-14.22	0.41998	0.74429	21	-18.768	0.94811	0.99976
"121"	"Herpes simplex virus 1 infection"	59	1.0052	0.020885	0.21233	-1.0052	0.97911	1	-29.846	0.97137	0.99992	35	-16.744	0.31211	0.68663	24	-26.576	0.99976	0.99976
"122"	"Hippo signaling pathway"	34	-0.0032092	0.5099	0.89097	0.0032092	0.4901	1	-21.19	0.85284	0.99992	19	-17.453	0.86301	0.95997	15	-12.259	0.61677	0.99976
"123"	"Histidine metabolism"	10	0.74128	0.077009	0.42705	-0.74128	0.92299	1	0.73687	0.0015068	0.05837	6	0.46145	0.01269	0.20688	4	0.59993	0.032194	0.43022
"124"	"Homologous recombination"	8	-0.59381	0.87201	1	0.59381	0.12799	0.81328	-8.4396	0.49025	0.85752	5	-10.259	0.82442	0.9539	3	-0.53698	0.092954	0.64242
"125"	"Human T-cell leukemia virus 1 infection"	61	0.31877	0.26478	0.76187	-0.31877	0.73522	1	-27.363	0.86282	0.99992	30	-18.904	0.69553	0.87557	31	-19.787	0.86126	0.99976
"126"	"Human cytomegalovirus infection"	77	0.4351	0.20214	0.66142	-0.4351	0.79786	1	-32.004	0.93163	0.99992	43	-20.918	0.52623	0.79128	34	-24.638	0.98654	0.99976
"127"	"Human immunodeficiency virus 1 infection"	80	0.14901	0.37127	0.85764	-0.14901	0.62873	1	-30.272	0.84302	0.99992	41	-20.132	0.50954	0.79128	39	-22.715	0.89928	0.99976
"128"	"Human papillomavirus infection"	110	-0.77177	0.93637	1	0.77177	0.063632	0.72918	-40.515	0.9946	0.99992	53	-30.419	0.98762	0.99785	57	-26.95	0.93039	0.99976
"129"	"Huntington disease"	113	-0.31381	0.71708	0.99213	0.31381	0.28292	0.97306	-25.382	0.026679	0.25283	54	-21.116	0.30143	0.68339	59	-14.925	0.02114	0.3746
"130"	"Hypertrophic cardiomyopathy (HCM)"	48	1.257	0.0054167	0.097182	-1.257	0.99458	1	-16.24	0.08118	0.38687	25	-5.3932	0.0015797	0.20377	23	-17.837	0.87516	0.99976
"131"	"IL-17 signaling pathway"	25	0.87525	0.036678	0.28684	-0.87525	0.96332	1	-19.846	0.91921	0.99992	13	-10.899	0.4658	0.77896	12	-17.3	0.97866	0.99976
"132"	"Inflammatory bowel disease (IBD)"	8	0.16121	0.35497	0.85764	-0.16121	0.64503	1	-8.9718	0.54909	0.92018	5	-7.5762	0.56432	0.80193	3	-4.87	0.47207	0.93776
"133"	"Inflammatory mediator regulation of TRP channels"	29	-0.034572	0.47917	0.88954	0.034572	0.52083	1	-14.194	0.25363	0.59505	12	-8.2344	0.22975	0.57341	17	-11.62	0.45963	0.93776
"134"	"Influenza A"	56	-0.0063603	0.51683	0.89097	0.0063603	0.48317	1	-23.302	0.58006	0.95632	27	-15.146	0.36296	0.72924	29	-17.766	0.73478	0.99976
"135"	"Inositol phosphate metabolism"	24	-0.58373	0.87781	1	0.58373	0.12219	0.79292	-17.387	0.79135	0.99992	13	-15.658	0.89473	0.98191	11	-8.6612	0.39569	0.93776
"136"	"Insulin resistance"	53	0.84404	0.038947	0.29697	-0.84404	0.96105	1	-22.687	0.59136	0.9622	26	-8.9613	0.021831	0.24937	27	-22.992	0.9892	0.99976
"137"	"Insulin secretion"	22	-0.76753	0.94082	1	0.76753	0.059176	0.72918	-11.786	0.26625	0.61304	10	-9.2857	0.41152	0.73853	12	-7.4824	0.22454	0.78406
"138"	"Insulin signaling pathway"	77	0.78852	0.06202	0.38604	-0.78852	0.93798	1	-28.09	0.65682	0.99337	34	-12.81	0.063899	0.36695	43	-26.199	0.98112	0.99976
"139"	"Intestinal immune network for IgA production"	2	-0.24216	0.68089	0.99213	0.24216	0.31911	0.9733	-6.2426	0.71928	0.99992	0				2	-6.2426	0.74938	0.99976
"140"	"JAK-STAT signaling pathway"	18	0.14111	0.37943	0.85764	-0.14111	0.62057	1	-17.225	0.89733	0.99992	7	-7.3277	0.39268	0.73853	11	-16.189	0.9754	0.99976
"141"	"Kaposi sarcoma-associated herpesvirus infection"	59	0.0064452	0.50762	0.89097	-0.0064452	0.49238	1	-27.608	0.89648	0.99992	29	-17.704	0.60712	0.83479	30	-21.31	0.94385	0.99976
"142"	"Legionellosis"	23	-0.36364	0.74124	0.99213	0.36364	0.25876	0.94152	-8.0206	0.031636	0.26802	13	-7.6495	0.15876	0.51814	10	-3.4421	0.047687	0.47473
"143"	"Leishmaniasis"	15	-0.55603	0.8592	1	0.55603	0.1408	0.83335	-13.695	0.70304	0.99733	4	-8.3098	0.7238	0.88737	11	-10.982	0.66397	0.99976
"144"	"Leukocyte transendothelial migration"	50	0.81315	0.052563	0.35037	-0.81315	0.94744	1	-20.562	0.4003	0.76344	29	-14.302	0.24922	0.59999	21	-14.922	0.6955	0.99976
"145"	"Linoleic acid metabolism"	3	-0.085912	0.5881	0.93911	0.085912	0.4119	1	-10.163	0.90103	0.99992	0				3	-10.163	0.92788	0.99976
"146"	"Long-term depression"	24	0.39537	0.22551	0.70907	-0.39537	0.77449	1	-10.844	0.1416	0.45743	14	-6.7037	0.082066	0.39947	10	-8.8682	0.45666	0.93776
"147"	"Long-term potentiation"	29	-0.70566	0.89969	1	0.70566	0.10031	0.7649	-10.22	0.036736	0.27328	15	-10.73	0.35726	0.72675	14	-3.6029	0.018253	0.3746
"148"	"Longevity regulating pathway"	44	0.18097	0.35944	0.85764	-0.18097	0.64056	1	-24.014	0.86049	0.99992	25	-16.051	0.56426	0.80193	19	-18.131	0.94934	0.99976
"149"	"Lysine degradation"	22	0.50326	0.15056	0.5932	-0.50326	0.84944	1	-8.3887	0.057824	0.31493	12	-5.6792	0.070082	0.38545	10	-6.2212	0.19234	0.78226
"150"	"Lysosome"	41	-0.088017	0.54614	0.9203	0.088017	0.45386	1	-25.42	0.95173	0.99992	22	-20.052	0.92547	0.98191	19	-15.765	0.8287	0.99976
"151"	"MAPK signaling pathway"	80	-0.46505	0.82815	1	0.46505	0.17185	0.93786	-28.057	0.6347	0.98389	37	-21.263	0.739	0.88737	43	-18.546	0.44507	0.93776
"152"	"Malaria"	13	1.5417	0.00087132	0.023163	-1.5417	0.99913	1	-9.7141	0.37217	0.73651	11	-5.6098	0.093188	0.41309	2	-11.61	0.98617	0.99976
"153"	"Mannose type O-glycan biosynthesis"	1	0	0.48706	0.88954	0	0.51294	1	-8.2095	0.93209	0.99992	1	-8.2095	0.92991	0.98191	0			
"154"	"Maturity onset diabetes of the young"	1	0	0.48706	0.88954	0	0.51294	1	-8.2095	0.93209	0.99992	1	-8.2095	0.92991	0.98191	0			
"155"	"Measles"	40	-0.060946	0.54468	0.9203	0.060946	0.45532	1	-25.407	0.9507	0.99992	16	-14.582	0.70367	0.88182	24	-20.895	0.96996	0.99976
"156"	"Melanogenesis"	23	-0.13319	0.58232	0.93559	0.13319	0.41768	1	-12.85	0.29974	0.63456	12	-11.209	0.54645	0.80193	11	-6.8735	0.21348	0.78406
"157"	"Melanoma"	14	0.095853	0.42257	0.88954	-0.095853	0.57743	1	-14.849	0.8325	0.99992	9	-12.439	0.81325	0.9472	5	-8.1576	0.71305	0.99976
"158"	"Metabolism of xenobiotics by cytochrome P450"	19	0.63144	0.10857	0.50174	-0.63144	0.89143	1	-8.5341	0.098027	0.40403	11	-2.1655	0.010292	0.20688	8	-10.613	0.74938	0.99976
"159"	"MicroRNAs in cancer"	43	0.56644	0.12618	0.54506	-0.56644	0.87382	1	-27.275	0.98595	0.99992	26	-19.486	0.82543	0.9539	17	-19.281	0.98111	0.99976
"160"	"Mineral absorption"	12	-2.2812	0.99999	1	2.2812	8.5576e-06	0.00087003	-4.164	0.031028	0.26802	4	-5.5898	0.42748	0.74683	8	-1.1473	0.026757	0.3746
"161"	"Mismatch repair"	7	-0.59641	0.89195	1	0.59641	0.10805	0.79024	-10.896	0.78896	0.99992	5	-13.04	0.95825	0.99785	2	0.23285	0.12042	0.67723
"162"	"Mitophagy"	33	1.7009	0.0009474	0.023163	-1.7009	0.99905	1	-18.405	0.61178	0.96986	18	-7.5658	0.049528	0.34702	15	-19.011	0.98771	0.99976
"163"	"Morphine addiction"	14	0.67668	0.091655	0.49376	-0.67668	0.90835	1	-10.621	0.41531	0.7819	9	-6.6817	0.22157	0.57298	5	-8.8071	0.77603	0.99976
"164"	"Mucin type O-glycan biosynthesis"	1	0.041178	0.45526	0.88954	-0.041178	0.54474	1	-1.8405	0.37429	0.73651	1	-1.8405	0.36913	0.73577	0			
"165"	"N-Glycan biosynthesis"	13	0.46187	0.16772	0.62384	-0.46187	0.83228	1	-14.425	0.8445	0.99992	8	-6.271	0.22885	0.57341	5	-15.327	0.99685	0.99976
"166"	"NF-kappa B signaling pathway"	20	1.1534	0.014997	0.16457	-1.1534	0.985	1	-20.269	0.97031	0.99992	11	-9.4973	0.42101	0.74429	9	-19.716	0.99919	0.99976
"167"	"NOD-like receptor signaling pathway"	50	0.61679	0.10857	0.50174	-0.61679	0.89143	1	-22.975	0.67608	0.99477	20	-7.905	0.049371	0.34702	30	-23.207	0.98341	0.99976
"168"	"Natural killer cell mediated cytotoxicity"	27	-0.37284	0.76768	0.99213	0.37284	0.23232	0.93786	-15.693	0.49966	0.86589	16	-13.191	0.56087	0.80193	11	-8.678	0.39761	0.93776
"169"	"Necroptosis"	58	-0.29482	0.69812	0.99213	0.29482	0.30188	0.97306	-20.615	0.2416	0.58243	22	-7.2317	0.0149	0.21073	36	-20.513	0.81527	0.99976
"170"	"Neomycin, kanamycin and gentamicin biosynthesis"	2	1.4166	0.0031409	0.059873	-1.4166	0.99686	1	0.51722	0.089601	0.40403	1	1.8729	0.082404	0.39947	1	-1.1415	0.31232	0.87169
"171"	"Neuroactive ligand-receptor interaction"	9	1.1642	0.0097388	0.13501	-1.1642	0.99026	1	-6.2917	0.22168	0.55421	9	-6.2917	0.18967	0.55227	0			
"172"	"Neurotrophin signaling pathway"	48	-0.2526	0.69674	0.99213	0.2526	0.30326	0.97306	-22.601	0.6784	0.99477	19	-14.241	0.57788	0.81191	29	-17.55	0.71467	0.99976
"173"	"Nicotinate and nicotinamide metabolism"	18	-0.66886	0.90318	1	0.66886	0.096819	0.7649	-16.32	0.84369	0.99992	7	-7.6795	0.43149	0.74943	11	-14.75	0.93827	0.99976
"174"	"Nitrogen metabolism"	7	0.94794	0.023519	0.22417	-0.94794	0.97648	1	-1.5887	0.035619	0.2716	4	-0.074028	0.039345	0.3246	3	-2.3413	0.21152	0.78406
"175"	"Non-alcoholic fatty liver disease (NAFLD)"	96	-0.21797	0.66222	0.99154	0.21797	0.33778	1	-25.395	0.10879	0.41059	39	-15.392	0.11298	0.44453	57	-20.225	0.31725	0.87169
"176"	"Non-homologous end-joining"	5	0.63932	0.093895	0.49376	-0.63932	0.9061	1	-4.7752	0.29361	0.6281	5	-4.7752	0.26033	0.61855	0			
"177"	"Non-small cell lung cancer"	23	-0.034354	0.50774	0.89097	0.034354	0.49226	1	-16.493	0.68423	0.99733	12	-13.613	0.7906	0.92445	11	-9.6304	0.50908	0.97824
"178"	"Notch signaling pathway"	6	0.12643	0.39367	0.85764	-0.12643	0.60633	1	-17.042	0.99686	0.99992	6	-17.042	0.99375	0.99785	0			
"179"	"Nucleotide excision repair"	11	0.33401	0.25957	0.76187	-0.33401	0.74043	1	-11.829	0.6953	0.99733	7	-8.2309	0.49353	0.79128	4	-8.7278	0.79573	0.99976
"180"	"Olfactory transduction"	11	-0.57929	0.87989	1	0.57929	0.12011	0.79292	-11.525	0.66433	0.99477	3	-5.8409	0.55145	0.80193	8	-9.9371	0.68678	0.99976
"181"	"One carbon pool by folate"	11	-0.21914	0.6762	0.99213	0.21914	0.3238	0.97782	-8.8077	0.36346	0.72932	7	-7.9579	0.4627	0.77896	4	-4.0785	0.30597	0.87169
"182"	"Oocyte meiosis"	41	-0.97581	0.96753	1	0.97581	0.032473	0.55146	-12.568	0.026123	0.25283	17	-11.414	0.33739	0.70792	24	-6.8208	0.017329	0.3746
"183"	"Osteoclast differentiation"	32	-0.82896	0.95027	1	0.82896	0.049727	0.6894	-21.608	0.89402	0.99992	10	-13.576	0.83639	0.95437	22	-16.907	0.83279	0.99976
"184"	"Other glycan degradation"	6	0.57825	0.12688	0.54506	-0.57825	0.87312	1	-7.3817	0.47587	0.84877	4	-4.4623	0.30683	0.68529	2	-6.4748	0.76996	0.99976
"185"	"Other types of O-glycan biosynthesis"	4	0.42633	0.17765	0.63542	-0.42633	0.82235	1	-5.8677	0.47073	0.84455	4	-5.8677	0.45882	0.77868	0			
"186"	"Ovarian steroidogenesis"	9	0.1513	0.38857	0.85764	-0.1513	0.61143	1	-13.071	0.88012	0.99992	3	-5.8894	0.55692	0.80193	6	-11.844	0.9118	0.99976
"187"	"Oxidative phosphorylation"	93	-0.89795	0.96473	1	0.89795	0.035266	0.55146	-17.962	0.001531	0.05837	33	-13.211	0.096463	0.41521	60	-12.565	0.0015796	0.09288
"188"	"Oxytocin signaling pathway"	63	-0.38703	0.77613	0.99623	0.38703	0.22387	0.93786	-18.515	0.060888	0.3258	28	-11.156	0.056011	0.34702	35	-14.861	0.25511	0.83337
"189"	"PI3K-Akt signaling pathway"	101	0.20438	0.32703	0.83819	-0.20438	0.67297	1	-35.064	0.91443	0.99992	52	-21.215	0.35498	0.72675	49	-28.486	0.98951	0.99976
"190"	"PPAR signaling pathway"	35	1.6497	0.00058729	0.021628	-1.6497	0.99941	1	-10.533	0.022448	0.24442	21	-5.0122	0.0045307	0.20688	14	-10.515	0.45502	0.93776
"191"	"Pancreatic cancer"	31	0.64095	0.10673	0.50174	-0.64095	0.89327	1	-20.604	0.86758	0.99992	17	-13.023	0.51521	0.79128	14	-16.309	0.93884	0.99976
"192"	"Pancreatic secretion"	23	0.032076	0.4573	0.88954	-0.032076	0.5427	1	-11.419	0.17881	0.50035	14	-10.182	0.34515	0.71528	9	-5.5557	0.18708	0.78226
"193"	"Pantothenate and CoA biosynthesis"	8	-0.28923	0.70113	0.99213	0.28923	0.29887	0.97306	-9.5682	0.61372	0.96986	4	-8.8354	0.77165	0.91672	4	-4.6961	0.37064	0.9067
"194"	"Parathyroid hormone synthesis, secretion and action"	23	0.2569	0.29603	0.79902	-0.2569	0.70397	1	-16.657	0.70012	0.99733	14	-15.033	0.83805	0.95437	9	-7.8775	0.41057	0.93776
"195"	"Parkinson disease"	98	-0.42979	0.77738	0.99623	0.42979	0.22262	0.93786	-19.111	0.001379	0.05837	36	-11.067	0.010767	0.20688	62	-15.594	0.015538	0.3746
"196"	"Pathogenic Escherichia coli infection"	33	-0.072823	0.57185	0.93559	0.072823	0.42815	1	-14.379	0.20051	0.53123	19	-9.798	0.14799	0.49947	14	-10.662	0.47167	0.93776
"197"	"Pathways in cancer"	140	0.57408	0.11135	0.50691	-0.57408	0.88865	1	-38.509	0.79542	0.99992	74	-27.134	0.50912	0.79128	66	-27.354	0.8563	0.99976
"198"	"Pentose and glucuronate interconversions"	7	0.4321	0.18156	0.63652	-0.4321	0.81844	1	-0.66429	0.019564	0.23868	3	0.53995	0.04546	0.34702	4	-1.3464	0.09833	0.64242
"199"	"Pentose phosphate pathway"	22	-0.69503	0.92127	1	0.69503	0.078734	0.75043	-8.3825	0.057624	0.31493	9	-2.9856	0.033587	0.31082	13	-8.4205	0.28404	0.8504
"200"	"Peroxisome"	42	0.51477	0.1517	0.5932	-0.51477	0.8483	1	-19.506	0.48923	0.85752	21	-9.4047	0.082249	0.39947	21	-18.181	0.9274	0.99976
"201"	"Pertussis"	28	0.46698	0.17225	0.63297	-0.46698	0.82775	1	-12.974	0.20204	0.53123	14	-9.2203	0.2505	0.59999	14	-9.1281	0.30504	0.87169
"202"	"Phagosome"	59	0.76872	0.060653	0.3854	-0.76872	0.93935	1	-16.191	0.022637	0.24442	32	-12.12	0.054543	0.34702	27	-10.74	0.10185	0.65092
"203"	"Phenylalanine metabolism"	6	-0.023151	0.50747	0.89097	0.023151	0.49253	1	-3.7463	0.13313	0.45201	2	0.046099	0.10786	0.44453	4	-4.6209	0.36253	0.9067
"204"	"Phenylalanine, tyrosine and tryptophan biosynthesis"	2	-0.74573	0.92542	1	0.74573	0.074579	0.75043	-0.47025	0.14408	0.45775	0				2	-0.47025	0.1654	0.75009
"205"	"Phosphatidylinositol signaling system"	28	-0.19142	0.62489	0.96748	0.19142	0.37511	1	-20.891	0.90438	0.99992	14	-16.117	0.9025	0.98191	14	-13.427	0.76436	0.99976
"206"	"Phospholipase D signaling pathway"	40	1.1624	0.0092829	0.13482	-1.1624	0.99072	1	-17.056	0.25838	0.60157	26	-10.526	0.057253	0.34702	14	-14.486	0.84698	0.99976
"207"	"Phosphonate and phosphinate metabolism"	2	-0.037991	0.53027	0.90861	0.037991	0.46973	1	-1.5352	0.2239	0.55521	1	-1.1809	0.30099	0.68339	1	-0.99023	0.29731	0.86543
"208"	"Phototransduction"	2	-0.096891	0.57522	0.93559	0.096891	0.42478	1	-6.6761	0.75931	0.99992	0				2	-6.6761	0.78701	0.99976
"209"	"Platelet activation"	53	1.1863	0.007234	0.11612	-1.1863	0.99277	1	-19.41	0.24443	0.58243	31	-13.407	0.11792	0.44899	22	-14.212	0.57472	0.99976
"210"	"Porphyrin and chlorophyll metabolism"	18	1.1014	0.013479	0.15812	-1.1014	0.98652	1	-6.3549	0.034627	0.27084	12	-5.5572	0.065483	0.36695	6	-3.148	0.13514	0.685
"211"	"Primary bile acid biosynthesis"	6	-0.80783	0.93727	1	0.80783	0.062734	0.72918	-3.488	0.11772	0.42745	2	-0.8486	0.16136	0.5209	4	-3.6718	0.26631	0.8504
"212"	"Primary immunodeficiency"	3	-0.054533	0.56512	0.93559	0.054533	0.43488	1	-10.31	0.90801	0.99992	0				3	-10.31	0.93353	0.99976
"213"	"Prion diseases"	21	0.26484	0.29171	0.7944	-0.26484	0.70829	1	-15.903	0.72122	0.99992	14	-16.146	0.90392	0.98191	7	-4.7107	0.19785	0.78226
"214"	"Progesterone-mediated oocyte maturation"	25	-0.36503	0.75187	0.99213	0.36503	0.24813	0.94152	-16.379	0.65791	0.99337	13	-14.848	0.84721	0.95437	12	-8.1863	0.28863	0.8504
"215"	"Prolactin signaling pathway"	24	-0.20445	0.6632	0.99154	0.20445	0.3368	1	-15.223	0.57445	0.95222	10	-11.044	0.60628	0.83479	14	-10.597	0.46432	0.93776
"216"	"Propanoate metabolism"	29	0.97344	0.020036	0.21072	-0.97344	0.97996	1	-8.1915	0.0090098	0.1832	18	-3.55	0.002688	0.20377	11	-8.7593	0.40694	0.93776
"217"	"Prostate cancer"	30	0.63266	0.10102	0.50174	-0.63266	0.89898	1	-21.922	0.93898	0.99992	18	-13.71	0.53418	0.79334	12	-17.87	0.98568	0.99976
"218"	"Proteasome"	39	-3.6568	1	1	3.6568	5.9508e-13	1.815e-10	-3.6071	7.5365e-06	0.0011493	4	-5.2853	0.39367	0.73853	35	-2.021	3.5183e-06	0.0010344
"219"	"Protein digestion and absorption"	26	-1.5222	0.99875	1	1.5222	0.0012476	0.047565	-12.373	0.19964	0.53123	6	-6.0194	0.31451	0.68683	20	-10.81	0.28557	0.8504
"220"	"Protein export"	14	0.22046	0.33037	0.83969	-0.22046	0.66963	1	-7.4126	0.134	0.45201	5	-1.4349	0.054643	0.34702	9	-8.1756	0.44393	0.93776
"221"	"Protein processing in endoplasmic reticulum"	97	0.8828	0.035028	0.28115	-0.8828	0.96497	1	-24.859	0.078908	0.38687	55	-14.86	0.0065514	0.20688	42	-20.773	0.72208	0.99976
"222"	"Proteoglycans in cancer"	83	0.90372	0.047872	0.33184	-0.90372	0.95213	1	-22.903	0.09635	0.40403	53	-18.871	0.13239	0.47373	30	-13.013	0.21662	0.78406
"223"	"Proximal tubule bicarbonate reclamation"	10	-0.61781	0.886	1	0.61781	0.114	0.79024	-3.9488	0.053053	0.31493	6	-4.9572	0.22055	0.57298	4	-0.17224	0.051766	0.47473
"224"	"Purine metabolism"	56	-1.5759	0.99952	1	1.5759	0.00048219	0.024512	-16.793	0.045465	0.29493	23	-11.494	0.15716	0.51814	33	-12.279	0.097078	0.64242
"225"	"Pyrimidine metabolism"	28	-0.95024	0.96203	1	0.95024	0.037969	0.55146	-19.17	0.79992	0.99992	11	-9.1653	0.38394	0.73853	17	-17.23	0.93241	0.99976
"226"	"Pyruvate metabolism"	34	0.10312	0.42588	0.88954	-0.10312	0.57412	1	-9.3276	0.010161	0.18392	17	-7.2809	0.055327	0.34702	17	-5.9103	0.042258	0.47053
"227"	"RIG-I-like receptor signaling pathway"	21	0.74529	0.066113	0.39538	-0.74529	0.93389	1	-19.666	0.94987	0.99992	6	-5.1567	0.23688	0.58628	15	-20.007	0.99439	0.99976
"228"	"RNA degradation"	36	-0.38616	0.76547	0.99213	0.38616	0.23453	0.93786	-21.097	0.78541	0.99992	21	-16.704	0.73782	0.88737	15	-12.92	0.68721	0.99976
"229"	"RNA polymerase"	9	0.087583	0.43885	0.88954	-0.087583	0.56115	1	-22.164	0.99992	0.99992	5	-15.051	0.9895	0.99785	4	-16.419	0.99879	0.99976
"230"	"RNA transport"	92	0.51888	0.13876	0.58038	-0.51888	0.86124	1	-27.15	0.27134	0.61304	55	-22.508	0.41256	0.73853	37	-15.37	0.25012	0.82623
"231"	"Rap1 signaling pathway"	52	1.4352	0.0024164	0.052643	-1.4352	0.99758	1	-18.224	0.15715	0.47456	31	-12.973	0.095077	0.41521	21	-12.915	0.47178	0.93776
"232"	"Ras signaling pathway"	59	1.069	0.015108	0.16457	-1.069	0.98489	1	-28.088	0.91909	0.99992	32	-17.143	0.42519	0.74683	27	-22.859	0.98804	0.99976
"233"	"Regulation of actin cytoskeleton"	97	0.88478	0.034714	0.28115	-0.88478	0.96529	1	-24.89	0.080232	0.38687	58	-18.098	0.048936	0.34702	39	-17.183	0.38268	0.92219
"234"	"Regulation of lipolysis in adipocytes"	16	1.1407	0.011967	0.15208	-1.1407	0.98803	1	-14.913	0.77614	0.99992	11	-9.8996	0.46685	0.77896	5	-11.993	0.95753	0.99976
"235"	"Relaxin signaling pathway"	41	0.061464	0.43042	0.88954	-0.061464	0.56958	1	-18.298	0.36894	0.73548	19	-12.128	0.3468	0.71528	22	-13.709	0.51728	0.98598
"236"	"Renal cell carcinoma"	30	0.5121	0.1494	0.5932	-0.5121	0.8506	1	-11.507	0.068095	0.34615	16	-9.3262	0.18204	0.53531	14	-6.874	0.12403	0.67723
"237"	"Renin secretion"	19	-0.073003	0.55484	0.92473	0.073003	0.44516	1	-9.0567	0.12542	0.44481	9	-6.1821	0.18123	0.53531	10	-6.6189	0.22511	0.78406
"238"	"Renin-angiotensin system"	11	0.15619	0.38572	0.85764	-0.15619	0.61428	1	-6.0549	0.12863	0.45095	6	-2.8443	0.089849	0.41054	5	-5.8652	0.44779	0.93776
"239"	"Retinol metabolism"	9	-0.45383	0.82731	1	0.45383	0.17269	0.93786	-7.0813	0.29449	0.6281	3	-1.172	0.11462	0.44453	6	-7.8441	0.58822	0.99976
"240"	"Retrograde endocannabinoid signaling"	61	0.055264	0.46094	0.88954	-0.055264	0.53906	1	-17.115	0.040763	0.28913	29	-11.217	0.062166	0.36695	32	-12.952	0.16839	0.75009
"241"	"Rheumatoid arthritis"	16	-1.0821	0.98027	1	1.0821	0.019726	0.4011	-11.857	0.45843	0.82824	4	-12.585	0.96525	0.99785	12	-6.4253	0.14533	0.70228
"242"	"Riboflavin metabolism"	5	-0.76028	0.91715	1	0.76028	0.08285	0.7649	-3.6033	0.19377	0.53001	2	-5.8957	0.66134	0.87296	3	0.16203	0.063646	0.5104
"243"	"Ribosome"	111	-1.2589	0.99431	1	1.2589	0.0056903	0.14463	-22.057	0.0021789	0.07384	40	-14.656	0.064831	0.36695	71	-16.578	0.011707	0.3746
"244"	"Ribosome biogenesis in eukaryotes"	22	0.22804	0.31852	0.82329	-0.22804	0.68148	1	-18.92	0.9144	0.99992	11	-13.834	0.85369	0.95437	11	-12.923	0.84102	0.99976
"245"	"SNARE interactions in vesicular transport"	18	-0.37956	0.76607	0.99213	0.37956	0.23393	0.93786	-16.883	0.87891	0.99992	8	-12.587	0.8505	0.95437	10	-11.393	0.73119	0.99976
"246"	"Salivary secretion"	22	0.42764	0.18955	0.65698	-0.42764	0.81045	1	-11.491	0.23989	0.58243	12	-7.7943	0.19315	0.55641	10	-8.506	0.41569	0.93776
"247"	"Salmonella infection"	45	0.20311	0.34072	0.85764	-0.20311	0.65928	1	-15.642	0.10677	0.41059	19	-8.2981	0.07157	0.38648	26	-13.485	0.35853	0.9067
"248"	"Selenocompound metabolism"	9	-0.59293	0.88982	1	0.59293	0.11018	0.79024	-1.8703	0.021018	0.24442	3	-1.3498	0.12474	0.45182	6	-1.3362	0.053286	0.47473
"249"	"Serotonergic synapse"	26	0.40907	0.20398	0.66142	-0.40907	0.79602	1	-13.462	0.29347	0.6281	14	-10.015	0.32777	0.70541	12	-8.9984	0.37179	0.9067
"250"	"Shigellosis"	39	0.076835	0.43011	0.88954	-0.076835	0.56989	1	-18.388	0.44865	0.81938	14	-6.8392	0.088088	0.41054	25	-17.849	0.82799	0.99976
"251"	"Signaling pathways regulating pluripotency of stem cells"	19	-0.049402	0.53662	0.91435	0.049402	0.46338	1	-13.325	0.51296	0.87895	9	-9.5572	0.52414	0.79128	10	-9.3007	0.50614	0.97824
"252"	"Small cell lung cancer"	34	-0.44486	0.81702	1	0.44486	0.18298	0.93786	-26.284	0.99371	0.99992	15	-18.772	0.97526	0.99785	19	-18.481	0.95912	0.99976
"253"	"Sphingolipid metabolism"	7	-0.53359	0.86561	1	0.53359	0.13439	0.81977	-15.615	0.98319	0.99992	2	-11.61	0.97762	0.99785	5	-11.133	0.92822	0.99976
"254"	"Sphingolipid signaling pathway"	45	0.14197	0.38778	0.85764	-0.14197	0.61222	1	-21.759	0.67785	0.99477	24	-17.293	0.72014	0.88737	21	-13.364	0.52379	0.98598
"255"	"Spliceosome"	94	1.5405	0.00098727	0.023163	-1.5405	0.99901	1	-35.652	0.96329	0.99992	76	-32.564	0.9299	0.98191	18	-14.561	0.7274	0.99976
"256"	"Staphylococcus aureus infection"	15	1.2381	0.0069759	0.11612	-1.2381	0.99302	1	-9.0002	0.22011	0.55421	11	-5.2491	0.077005	0.39947	4	-8.7242	0.79544	0.99976
"257"	"Starch and sucrose metabolism"	19	-2.6391	1	1	2.6391	1.4037e-07	2.1406e-05	-4.0132	0.0054875	0.13947	6	-6.9376	0.40718	0.73853	13	-0.13853	0.0015001	0.09288
"258"	"Steroid biosynthesis"	6	-0.46856	0.80999	1	0.46856	0.19001	0.93786	-10.787	0.82227	0.99992	1	-8.2095	0.92991	0.98191	5	-8.1448	0.71173	0.99976
"259"	"Steroid hormone biosynthesis"	6	0.41186	0.20601	0.66142	-0.41186	0.79399	1	-5.6111	0.28349	0.62747	4	-2.171	0.12316	0.45182	2	-6.6485	0.78471	0.99976
"260"	"Sulfur metabolism"	6	-0.55627	0.85246	1	0.55627	0.14754	0.83335	-2.1311	0.057191	0.31493	2	-1.8557	0.2393	0.58738	4	-1.2979	0.095939	0.64242
"261"	"Sulfur relay system"	6	-0.44453	0.79715	0.99933	0.44453	0.20285	0.93786	-4.6135	0.19463	0.53001	3	-2.1023	0.17439	0.53531	3	-4.4222	0.42092	0.93776
"262"	"Synaptic vesicle cycle"	24	-0.16682	0.63589	0.96973	0.16682	0.36411	1	-10.372	0.11331	0.42146	12	-12.313	0.66802	0.87557	12	-2.3555	0.013531	0.3746
"263"	"Synthesis and degradation of ketone bodies"	8	0.77252	0.055601	0.36082	-0.77252	0.9444	1	-6.4722	0.28404	0.62747	5	-3.8075	0.17874	0.53531	3	-5.6536	0.56217	0.99976
"264"	"Systemic lupus erythematosus"	22	0.73587	0.065631	0.39538	-0.73587	0.93437	1	-12.296	0.31493	0.65343	15	-11.528	0.44652	0.76297	7	-4.9223	0.2157	0.78406
"265"	"T cell receptor signaling pathway"	36	-0.70339	0.90654	1	0.70339	0.093458	0.7649	-18.176	0.49202	0.85752	14	-12.112	0.56067	0.80193	22	-13.589	0.50347	0.97824
"266"	"TGF-beta signaling pathway"	15	-0.269	0.69538	0.99213	0.269	0.30462	0.97306	-12.734	0.60483	0.96986	5	-5.1948	0.30089	0.68339	10	-11.922	0.77891	0.99976
"267"	"TNF signaling pathway"	26	-0.42568	0.79875	0.99933	0.42568	0.20125	0.93786	-21.107	0.94055	0.99992	7	-10.354	0.721	0.88737	19	-18.406	0.95716	0.99976
"268"	"Taste transduction"	2	-0.11877	0.5917	0.93995	0.11877	0.4083	1	-6.5903	0.75164	0.99992	1	-8.2095	0.92991	0.98191	1	-1.1105	0.30922	0.87169
"269"	"Taurine and hypotaurine metabolism"	2	-0.34663	0.74917	0.99213	0.34663	0.25083	0.94152	-6.0284	0.69838	0.99733	0				2	-6.0284	0.72957	0.99976
"270"	"Terpenoid backbone biosynthesis"	15	-0.66798	0.90274	1	0.66798	0.097265	0.7649	-12.358	0.56414	0.94023	3	-5.4875	0.51138	0.79128	12	-11.073	0.60299	0.99976
"271"	"Th1 and Th2 cell differentiation"	22	-1.4135	0.99802	1	1.4135	0.0019806	0.060408	-13.918	0.48847	0.85752	4	-8.9962	0.7853	0.92187	18	-11.146	0.36817	0.9067
"272"	"Th17 cell differentiation"	28	-0.95046	0.96207	1	0.95046	0.037935	0.55146	-14.62	0.34859	0.71356	9	-9.6453	0.53424	0.79334	19	-11.11	0.34184	0.88939
"273"	"Thermogenesis"	132	-0.21185	0.64099	0.97264	0.21185	0.35901	1	-29.097	0.056233	0.31493	56	-16.807	0.034536	0.31082	76	-23.919	0.32248	0.87785
"274"	"Thiamine metabolism"	7	-0.88532	0.96711	1	0.88532	0.032889	0.55146	-4.212	0.14248	0.45743	2	-6.5242	0.72276	0.88737	5	-0.85741	0.049846	0.47473
"275"	"Thyroid cancer"	11	-0.33992	0.7573	0.99213	0.33992	0.2427	0.93786	-7.2644	0.21518	0.54876	6	-8.3608	0.55963	0.80193	5	-1.616	0.078267	0.60554
"276"	"Thyroid hormone signaling pathway"	42	0.0027204	0.49479	0.89097	-0.0027204	0.50521	1	-19.993	0.54446	0.91746	28	-18.856	0.73634	0.88737	14	-7.962	0.19942	0.78226
"277"	"Thyroid hormone synthesis"	21	0.32253	0.25357	0.76187	-0.32253	0.74643	1	-7.3068	0.033712	0.27084	13	-6.1744	0.078634	0.39947	8	-3.9675	0.12403	0.67723
"278"	"Tight junction"	80	0.40641	0.19404	0.65758	-0.40641	0.80596	1	-29.21	0.7546	0.99992	42	-20.164	0.47996	0.78323	38	-21.183	0.8355	0.99976
"279"	"Toll-like receptor signaling pathway"	29	-0.46711	0.78996	0.99933	0.46711	0.21004	0.93786	-20.251	0.85423	0.99992	11	-11.785	0.67762	0.87557	18	-16.492	0.87229	0.99976
"280"	"Toxoplasmosis"	41	-0.69808	0.90397	1	0.69808	0.096026	0.7649	-19.124	0.45892	0.82824	13	-9.6838	0.33447	0.70792	28	-16.543	0.65681	0.99976
"281"	"Transcriptional misregulation in cancer"	23	0.74457	0.071384	0.40319	-0.74457	0.92862	1	-25.857	0.9989	0.99992	19	-24.547	0.99895	0.99895	4	-8.5051	0.77715	0.99976
"282"	"Tryptophan metabolism"	21	1.1857	0.0085948	0.13107	-1.1857	0.99141	1	-6.4272	0.018948	0.23868	13	-2.9707	0.010304	0.20688	8	-6.6263	0.33585	0.88939
"283"	"Tuberculosis"	54	-0.37131	0.76577	0.99213	0.37131	0.23423	0.93786	-21.617	0.42456	0.79204	24	-16.306	0.62219	0.85156	30	-14.419	0.35123	0.89792
"284"	"Type I diabetes mellitus"	5	0.27183	0.27181	0.77479	-0.27183	0.72819	1	-7.9401	0.62727	0.98112	3	-5.1535	0.4734	0.77929	2	-6.2426	0.74938	0.99976
"285"	"Type II diabetes mellitus"	18	0.1347	0.38428	0.85764	-0.1347	0.61572	1	-14.502	0.68936	0.99733	6	-3.8249	0.14085	0.48592	12	-15.056	0.91782	0.99976
"286"	"Tyrosine metabolism"	13	0.2682	0.28284	0.78424	-0.2682	0.71716	1	-4.8186	0.042902	0.29493	5	-0.57216	0.032219	0.30868	8	-5.6902	0.24784	0.82623
"287"	"Ubiquinone and other terpenoid-quinone biosynthesis"	6	0.36246	0.23421	0.72893	-0.36246	0.76579	1	-8.6212	0.6171	0.97019	5	-8.3529	0.64987	0.87296	1	-2.4397	0.45171	0.93776
"288"	"Ubiquitin mediated proteolysis"	51	-0.29374	0.71552	0.99213	0.29374	0.28448	0.97306	-25.176	0.8496	0.99992	21	-14.956	0.56015	0.80193	30	-20.312	0.90362	0.99976
"289"	"VEGF signaling pathway"	28	-0.36187	0.7407	0.99213	0.36187	0.2593	0.94152	-14.922	0.37918	0.73662	16	-14.436	0.68973	0.87557	12	-6.1238	0.12669	0.67723
"290"	"Valine, leucine and isoleucine degradation"	41	2.288	3.1912e-06	0.00048665	-2.288	1	1	-8.2478	0.00081017	0.05837	31	-3.8719	4.3737e-05	0.01299	10	-9.8834	0.57252	0.99976
"291"	"Vascular smooth muscle contraction"	40	0.41053	0.20094	0.66142	-0.41053	0.79906	1	-14.527	0.089314	0.40403	23	-11.823	0.18049	0.53531	17	-8.5313	0.16361	0.75009
"292"	"Vasopressin-regulated water reabsorption"	22	-0.69634	0.92166	1	0.69634	0.078343	0.75043	-7.1433	0.027355	0.25283	6	-3.4863	0.12139	0.45182	16	-6.2414	0.063273	0.5104
"293"	"Vibrio cholerae infection"	21	-0.5734	0.86892	1	0.5734	0.13108	0.81592	-10.187	0.15397	0.4696	10	-12.515	0.75238	0.89742	11	-2.1433	0.014027	0.3746
"294"	"Viral carcinogenesis"	66	0.14908	0.37512	0.85764	-0.14908	0.62488	1	-24.653	0.50809	0.87553	38	-20.633	0.65358	0.87296	28	-13.814	0.34812	0.89777
"295"	"Viral myocarditis"	25	0.71271	0.071218	0.40319	-0.71271	0.92878	1	-12.035	0.20117	0.53123	14	-7.2867	0.11031	0.44453	11	-9.9235	0.54366	0.99976
"296"	"Vitamin B6 metabolism"	3	0.090348	0.45737	0.88954	-0.090348	0.54263	1	-1.0521	0.10246	0.41059	2	-1.0252	0.17368	0.53531	1	-0.37244	0.23971	0.81004
"297"	"Vitamin digestion and absorption"	5	0.73053	0.067678	0.39696	-0.73053	0.93232	1	-4.5295	0.27086	0.61304	3	-0.43374	0.078848	0.39947	2	-6.6306	0.78322	0.99976
"298"	"Wnt signaling pathway"	37	-0.15985	0.61484	0.9667	0.15985	0.38516	1	-17.865	0.44385	0.81551	16	-11.829	0.41272	0.73853	21	-13.388	0.52652	0.98598
"299"	"alpha-Linolenic acid metabolism"	4	-0.11439	0.57743	0.93559	0.11439	0.42257	1	-9.5634	0.83567	0.99992	0				4	-9.5634	0.85683	0.99976
"300"	"beta-Alanine metabolism"	18	1.6101	0.00063821	0.021628	-1.6101	0.99936	1	-6.3552	0.034632	0.27084	12	-2.4114	0.0078503	0.20688	6	-7.5973	0.56092	0.99976
"301"	"cAMP signaling pathway"	56	0.33284	0.25398	0.76187	-0.33284	0.74602	1	-18.347	0.10776	0.41059	30	-14.296	0.22262	0.57298	26	-11.57	0.17609	0.76131
"302"	"cGMP-PKG signaling pathway"	56	0.51508	0.14908	0.5932	-0.51508	0.85092	1	-13.856	0.005473	0.13947	30	-10.693	0.039182	0.3246	26	-8.8487	0.041155	0.47053
"303"	"mRNA surveillance pathway"	43	0.56688	0.126	0.54506	-0.56688	0.874	1	-22.438	0.78024	0.99992	23	-16.353	0.64188	0.86653	20	-15.364	0.76385	0.99976
"304"	"mTOR signaling pathway"	59	-1.2503	0.9954	1	1.2503	0.0045954	0.12742	-24.019	0.59309	0.9622	22	-18.409	0.83634	0.95437	37	-16.135	0.32603	0.87939
"305"	"p53 signaling pathway"	11	-0.0085678	0.51503	0.89097	0.0085678	0.48497	1	-13.99	0.86995	0.99992	6	-8.4667	0.57091	0.80743	5	-11.476	0.94135	0.99976
